Medical Devices

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

A novel device that treats hypertension from outside the artery shows early promise, challenging market leaders and offering new hope for millions.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

NFL legend Brett Favre reports gains from an experimental Parkinson's drug, but what does the science say about this potential breakthrough treatment?

A new wave of MedTech innovators is ditching fragmented systems for unified, AI-driven platforms, accelerating life-saving device development. Here's why.

Senti Biosciences advances its AML cell therapy to a registrational trial after FDA meeting and a key discovery that quadruples patient response rates.

Rubicon Point Partners and Canyon Partners Real Estate acquired a Santa Clara R&D campus, signaling a major bet on Silicon Valley's real estate backed by accelerating demand for specialized flex space.

Minset's mCoder AI achieved state-of-the-art results on a demanding industry benchmark, signaling a new era of accurate, auditable autonomous coding.

With a major new financing round, BlueWind Medical is set to expand access to its innovative Revi® System for urgency urinary incontinence.

The biopharma posts record Q1 revenue and profit, driven by its flagship DefenCath and a key acquisition, while a promising pipeline signals future growth.

OrganOx names Terumo's Naoya Iwata as new CEO, signaling a major push to expand its life-saving organ transplant technology across the globe.

Koelis launches ProMap® Smart, an AI software that contours the prostate in under 5 seconds, boosting biopsy precision and streamlining patient care.

With a new CFO known for big-ticket financing and IPO readiness, clinical-stage OnCusp Therapeutics is gearing up for its next major growth spurt.

Fresh off its IPO, Agomab Therapeutics is presenting key data for its new IPF drug, AGMB-447, while courting investors on a multi-conference tour.

Atamyo's new gene therapy shows remarkable early results, potentially halting a severe, progressive muscular dystrophy that affects children.

With strong HIFU revenue and new clinical trials, EDAP TMS's upcoming Investor Day will reveal its strategy for medtech dominance and investor confidence.

A new six-month semaglutide implant is entering clinical trials, aiming to solve the adherence crisis plaguing GLP-1 drugs like Ozempic and Wegovy.

A new partnership aims to solve the massive underdiagnosis of a severe genetic disorder by offering free testing, a move with deep strategic implications.

The med spa industry is exploding, but a critical shortage of skilled estheticians threatens its growth. Discover how specialized training offers a solution.